Retinal diseases are putting more than 300 million people around the world at risk of losing their sight. Once patients lose their site, there is currently no way to get it back, but now scientists ...

Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...

A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

For generations, adults with amblyopia were told their vision loss was permanent, a childhood problem that medicine could not ...

“Temporary loss of vision in one eye for seconds or minutes, as if a curtain was pulled down, is known as amaurosis fugax and ...

A funding shortfall for a key copay assistance program to help make eye injections more affordable for low-income patients has caused widespread disruption in treatment, researchers have found. The ...

The human eye represents one of the body’s most complex and revealing organs, providing not only the gift of sight but also functioning as an early warning system for numerous health conditions. The ...

In life, few things are certain. But one is: It becomes harder to see well as you age. “There are three things we cannot avoid: death, taxes, and presbyopia, the gradual loss of the ability to read up ...